Abola P, Jabishvili G. Incidence of adverse and safety events in individuals with Parkinson’s disease treated with catechol-o-methyltransferase inhibitor opicapone as an add-on to levodopa treatment: a systematic review and meta-analysis. Prospect. Pharm. Sci. [Internet]. 2025 Aug. 13 [cited 2026 Jan. 20];23(4):175-8. Available from: https://prospects.wum.edu.pl/index.php/pps/article/view/563